Clinical Data
There is a growing body of evidence supporting InterVapor™ endoscopic lung volume reduction. Below is a selection of Uptake Medical’s scientific publications.
Publications
- Thermal Effect of Endoscopic Thermal Vapour Ablation on the Lung Surface in Human Ex Vivo Tissue
Henne, E., International Journal of Hyperthermia, 08/12 - Characterization of Outcomes 1 Year After Endoscopic Thermal Vapor Ablation for Patients with Heterogeneous Emphysema
Herth, F., International Journal of COPD, 07/12 - Comparison of Human Lung Tissue Mass Measurements from Ex Vivo Lungs and high Resolution CT Software Analysis
Henne, E., BMC Pulmonary Medicine, 05/12 - Rationale for the Development and the Mechanism of Action of Endoscopic Thermal Vapor Ablation (InterVapor) for the Treatment of Emphysema
Kesten, S., Journal of Bronchology & Interventional Pulmonology, 07/12 - Bronchoscopic Thermal Vapor Ablation Therapy in the Management of Heterogeneous Emphysema
Snell, G., European Respiratory Journal, 03/12 - Efficacy of Bronchoscopic Thermal Vapor Ablation and Lobar Fissure Completeness
Gompelmann, D., Respiration, 03/12 - Bronchoscopic Thermal Vapor Ablation in a Canine Model of Emphysema
Tuck, S., International Journal of COPD, 01/12 - Lung Volume Reduction by Bronchoscopic Administration of Steam
Emery, M., American Journal of Respiratory and Critical Care Medicine, 07/10 - A Feasibility and Safety Study of Bronchoscopic Thermal Vapor Ablation: A Novel Emphysema Therapy
Snell, G., Annals of Thoracic Surgery, 06/09
The InterVapor® System is CE marked and has TGA approval. It is under clinical investigation in the U.S.
Posters/Abstracts
- Efficacy of Bronchoscopic Thermal Vapor Ablation and Lobar Fissure Completeness
Gompelmann, D., European Respiratory Society 2011, 09/11 - Associations of Efficacy Outcomes Following Bronchoscopic Thermal Vapor Ablation (BTVA) for the Treatment of Heterogeneous Emphysema
Hopkins, P., European Respiratory Society 2011, 09/11 - High Resolution Computed Tomography (HRCT) Measurements of Lobar Volume Reduction Associated with Bronchoscopic Thermal Vapor Ablation (BTVA) in Patients with Heterogeneous Emphysema
Valipour, A., European Respiratory Society 2011, 09/11 - Sustained Efficacy from 3 to 6 Months Following Bronchoscopic Thermal Vapor Ablation (BTVA) in the Treatment of Heterogeneous Emphysema
Herth, F., European Respiratory Society 2011, 09/11 - The Efficacy of Bronchoscopic Thermal Vapor Ablation (BTVA) in Patients with Upper Lobe Emphysema
Snell, G., American Thoracic Society 2011, 06/11 - The Safety and Efficacy of Bronchoscopic Thermal Vapor Ablation (BTVA) in an Emphysematous Canine Model
Tuck, S., American Thoracic Society 2011, 06/11 - The Effect of Emphysema Heterogeneity on Durability of Benefits Following Lung Volume Reduction Surgery: A Retrospective Analysis of the NETT Study Data
Anderson, J., American Thoracic Society 2011, 06/11
